S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway
- 6 October 2017
- journal article
- Published by Taylor & Francis in Future Oncology
- Vol. 13 (23) , 2053-2063
Abstract
Aim: We explored the expression of S100A6 and its role in intrahepatic cholangiocarcinoma (ICC). Methods: The expression of S100A6 in ICC samples was detected by immunohistochemistry. In vitro experiments, we silenced and overexpressed S100A6 to investigate its role in cell functions. Results: The expression of S100A6 was markedly increased in ICC tissues and cell lines. S100A6 overexpression was an independent risk factor for patients’ survival. Silencing S100A6 resulted in a suppression of proliferation and p38/MAPK activity, while overexpressing S100A6 caused a promotion of proliferation and p38/MAPK. Discussion: S100A6 participated in the proliferation of ICC cells and correlated with a more aggressive behavior of ICC. Conclusion: S100A6 may serve as a novel prognostic marker and a potential therapeutic target for ICC patients.Keywords
This publication has 41 references indexed in Scilit:
- Lymph node dissection for intrahepatic cholangiocarcinoma: a critical review of the literature to dateJournal of Hepato-Biliary-Pancreatic Sciences, 2013
- S100A14 Stimulates Cell Proliferation and Induces Cell Apoptosis at Different Concentrations via Receptor for Advanced Glycation End Products (RAGE)PLOS ONE, 2011
- Cholangiocarcinoma—controversies and challengesNature Reviews Gastroenterology & Hepatology, 2011
- S100A6 Overexpression Is Associated with Poor Prognosis and Is Epigenetically Up-Regulated in Gastric CancerThe American Journal of Pathology, 2010
- S100A6 – New facts and featuresBiochemical and Biophysical Research Communications, 2009
- S100A6 Expression and Function in Human OsteosarcomaClinical Orthopaedics and Related Research, 2008
- Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in ScotlandEuropean Journal of Cancer, 2003
- Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitroJournal of Cellular Biochemistry, 2003
- S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinomaHepatology Research, 2002
- Calcyclin Is an Early Vasopressin-induced Gene in the Renal Collecting DuctJournal of Biological Chemistry, 2002